A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Recruiting · NCT06533332 · Registry updated 2026-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, liver disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, skin disorder, uterine disorder | Recruiting | Phase 1 | 2026-05-29 | NCT06533332 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EtiraRx Australia Pty Ltd | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Research SA | Adelaide | Australia | 18 |
| Icon Cancer Centre Adelaide | Adelaide | Australia | 1 |
| Macquarie University Health | Ryde | Australia | 1 |
| The Kinghorn Cancer Center | Sydney | Australia | 1 |
| Westmead Hospital | Westmead | Australia | 128 |